文献速递骨质疏松与代谢性骨病

根据糖尿病病程调整骨折概率:Manitoba BMD 注册研究

Adjusting fracture probability according to duration of diabetes: the Manitoba BMD Registry.
PubMed 文献 · Osteoporos Int · 2026-04-10

研究基于 Manitoba 骨密度注册中 54,609 名≥40 岁个体(含 5,274 名糖尿病者),比较类风湿关节炎(RA)输入与骨小梁评分(TBS)调整在 FRAX 基础上捕捉糖尿病相关骨折风险的效果。结果显示,糖尿病与主要骨质疏松性骨折(MOF)及髋部骨折风险独立相关,但部分被超额死亡抵消;TBS 调整与 RA 输入的获益因糖尿病病程和骨折结局而异。

要点

  • 糖尿病病程<5年者预测 MOF 无需 FRAX 调整。
  • 病程 5-10 年者 TBS 调整 FRAX 略优于未调整。
  • 髋部骨折风险各病程均升高,需用 TBS 调整。

核心结论

  • 糖尿病与 MOF 及髋部骨折风险独立于基线骨折概率相关,但该风险部分被超额死亡抵消。
  • TBS 调整与 RA 输入对改善骨折预测有互补获益,且获益因糖尿病病程和骨折结局不同而异。

研究设计与样本

  • 基于 Manitoba 骨密度计划注册数据的回顾性队列分析。
  • 纳入 54,609 名≥40 岁个体,平均年龄 63.8 岁,女性占 89.9%,其中糖尿病 5,274 人(9.7%)。
  • 平均观察 9.6 年,通过人群医疗数据确定新发 MOF(5,723 例,10.5%)和髋部骨折(1,715 例,3.1%)。
  • 采用 Cox 回归和 Fine-Gray 竞争死亡回归,在 FRAX 概率基础上评估 RA 输入和 TBS 调整前后糖尿病对骨折结局的影响。

主要发现

  • 糖尿病病程<5 年者预测 MOF 无需 FRAX 调整。
  • 糖尿病病程 5-10 年者,TBS 调整的 FRAX 略优于未调整的 FRAX 输出。
  • 糖尿病病程>10 年者,RA 输入的较大效应有益,无论是否联合 TBS。
  • 髋部骨折风险无论糖尿病病程长短均持续升高,需要 TBS 调整,无论是否联合 RA。

临床怎么用

  • 对糖尿病患者使用 FRAX 评估骨折风险时,可根据糖尿病病程考虑 TBS 调整或 RA 输入以优化预测。
  • 病程<5 年者预测 MOF 可沿用未调整 FRAX;病程 5-10 年可优先考虑 TBS 调整。
  • 病程>10 年者采用 RA 输入(可联合 TBS)可能改善 MOF 预测。
  • 髋部骨折风险预测在各病程阶段均应考虑 TBS 调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We studied the use of rheumatoid arthritis (RA) as an input to FRAX® and trabecular bone score (TBS) to modify FRAX-based probability in individuals with diabetes. Our results help to inform the use of FRAX and FRAXplus in patients with diabetes. BACKGROUND: Diabetes confers increased risk for fracture independently from FRAX-estimated fracture probability. PURPOSE: To compare the relative performance of the rheumatoid arthritis (RA) input and trabecular bone score (TBS) adjustment, alone or in combination, to capture FRAX-independent risk associated with diabetes. METHODS: We analyzed data on 54,609 individuals from the Manitoba Bone Density Program aged ≥ 40 years with FRAX-based probability and TBS measurements (mean age 63.8 years, 89.9% female) including 5274 (9.7%) with diabetes. Incident major osteoporotic fracture (MOF, 5723, 10.5%) and hip fractures (1715, 3.1%) were ascertained during mean 9.6 years observation from population-based healthcare data. The effect of diabetes on fracture outcomes was modeled without (Cox regression) and with competing mortality (Fine-Gray regression), adjusted for FRAX-based probability before and after RA input and TBS adjustment. RESULTS: For MOF prediction in those with diabetes duration less than 5 years, no FRAX adjustment was required. For those with duration 5-10 years, FRAX adjusted with TBS was slightly better than the unadjusted FRAX output. For those with diabetes duration greater than 10 years, the larger effect from RA was beneficial, with or without TBS. In contrast, hip fracture risk was consistently greater regardless of diabetes duration and required the use of TBS, with or without RA. CONCLUSION: Diabetes was associated with incident MOF and hip fracture independent of baseline fracture probability, but this risk was partially offset by excess mortality. TBS adjustment and RA input showed complementary benefits for improving fracture prediction that differed according to diabetes duration and fracture outcome.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Leslie WD, Hans D, Johansson H, et al. Adjusting fracture probability according to duration of diabetes: the Manitoba BMD Registry. Osteoporos Int. 2026. PMID: 41961087. doi:10.1007/s00198-026-08001-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。